BerGenBio Announces Safety Data from Dose Escalation Phase 1b in First Line NSCLC Patients

BerGenBio ASA Norway

View original content:https://www.prnewswire.co.uk/news-releases/bergenbio-announces-safety-data-from-dose-escalation-phase-1b-in-first-line-nsclc-patients-302268551.html